Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Hemoglobin A1c test is a common blood test performed for diagnosis and monitoring of type 1 and type 2 diabetes. A1c test results reflect the average blood sugar levels of an individual for the past two to three months. Hemoglobin (Hb) is a protein that links with sugars such as glucose found inside red blood cells. High amount of glucose linked (glycated) with hemoglobin molecules increases the risk of diabetes. HbA1c test reports the amount of HbA1c as a proportion of total hemoglobin in the blood stream.

Statistics:

The global hemoglobin A1c testing devices market is estimated to account for US$ 4,129.4 Mn in terms of value by the end of 2027.

Global Hemoglobin A1c Testing Devices Market: Drivers

Increasing prevalence of diabetes is expected to propel growth of the global hemoglobin A1c testing devices market over the forecast period. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

Moreover, increasing geriatric population is also expected to aid in growth of the market. For according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.         

Statistics:

North America held dominant position in the global hemoglobin A1c testing devices market in 2019, accounting for 36.8% share in terms of value, followed by Europe and Asia Pacific, respectively

Figure 1: Global Hemoglobin A1c Testing Devices Market Share (%) Value, By Region, 2019

HbA1c Testing Devices  | Coherent Market Insights

Global Hemoglobin A1c Testing Devices Market: Restraints

High test cost is expected to hinder growth of the global hemoglobin A1c testing devices market. Laboratory testing of hemoglobin A1c is a costly and time consuming affair, which restricts patients from seeking A1C testing. Even healthcare practitioners prefer blood glucose testing in case of emergencies.

Moreover, low adoption of hemoglobin A1c testing in emerging economies is also expected to aid in growth of the market. This is due to the lack of awareness and acceptance of hemoglobin A1c testing method by the healthcare fraternity and general population. One of the reasons for low acceptance of these solutions is the high cost compared to conventional blood glucose testing.

Global Hemoglobin A1c Testing Devices Market: Opportunities

High prevalence of undiagnosed diabetes in emerging economies is expected to offer lucrative growth opportunities for players in the market. For instance, according to the study, ‘The Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes, and Prediabetes’, published in the journal Diabetes Care, in April 2019, the economic burden associated with diagnosed diabetes, undiagnosed diabetes, prediabetes (adults), and gestational diabetes (mothers and newborns) reached US$ 327.2 billion, US$ 31.7 billion, US$ 43.4 billion for prediabetes, and US$ 1.6 billion for gestational diabetes, respectively, in 2017, in the U.S. 

Moreover, introducing cost-effective HbA1c tests and devices is also expected to aid in growth of the market.

Statistics:

The global hemoglobin A1c testing devices market was valued at US$ 1,863.7 Mn in 2019 and is forecast to reach a value of US$ 4,129.4 Mn by 2027 at a CAGR of 10.5% between 2020 and 2027.

Figure 2: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), 2016 - 2027

HbA1c Testing Devices  | Coherent Market Insights

Market Trends/Key Takeaways

The current trend is shifting towards the Clinical Laboratory Improvement Amendments (CLIA) waived tests and hence manufacturing CLIA waived tests will bolster the demand for CLIA waived HbA1c testing devices. Moreover, introduction of CLIA waived POC HbA1c testing devices will increase the market demand for POC devices and thus in turn will be beneficial for both manufacturers as well as customers.

Several studies have demonstrated higher efficacy of glucose tolerance test over hemoglobin A1c blood test. For instance, in March 2019, a study by City of Hope Diabetes and Metabolism Research Institute, published at the Endocrine Society’s ENDO 2019, reported that hemoglobin A1c blood test missed almost 73% of the people with diabetes in comparison to the oral glucose tolerance test.

Global Hemoglobin A1c Testing Devices Market: Competitive Landscape

Major players operating in the global hemoglobin A1c testing devices market include, Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Chek Diagnostics (Polymer Technology Systems, Inc.), Danaher Corporation (Beckman Coulter),  F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Siemens Healthcare, Tosoh Corporation, and Trinity Biotech plc.

Global Hemoglobin A1c Testing Devices Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in June 2019, Abbott Laboratories launched Afinion HbA1c Dx test, a 3-minute, in-office A1c blood test for diagnosing diabetes.

Similarly, in May 2019, Siemens Healthineers launched its new Atellica CH Enzymatic Hemoglobin A1c Assay to for diagnosing and monitoring diabetes.

Hemoglobin A1c Testing Devices are used for diagnosis and monitoring of type 1 and type 2 diabetes. Hemoglobin A1c test results reflect the average blood sugar levels of an individual for the past two to three months. Increasing prevalence of diabetes is expected to propel growth of the global hemoglobin A1c testing devices market over the forecast period.

Furthermore, increasing geriatric population, increasing healthcare infrastructure, and high prevalence of undiagnosed diabetes in emerging economies is also expected to propel the market growth during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the Hemoglobin A1c Testing Devices market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Hemoglobin A1c Testing Devices market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Chek Diagnostics (Polymer Technology Systems, Inc.), Danaher Corporation (Beckman Coulter), Hoffmann-La Roche Ltd., Menarini Group, Sebia, Siemens Healthcare, Tosoh Corporation, and Trinity Biotech plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Hemoglobin A1c Testing Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Hemoglobin A1c Testing Devices market

Detailed Segmentation:

  • Hemoglobin A1c Testing Devices Market, By Test Type:
    • Laboratory Testing Devices
    • Point-of-care Testing Devices
  • Hemoglobin A1c Testing Devices Market, By Technology:
    • Ion-Exchange HPLC
    • Immunoassay
    • Boronate Affinity Chromatography
    • Direct Enzymatic Assay
    • Others
  • Hemoglobin A1c Testing Devices Market, By Region:
    • North America
      • By Test Type:
        • Laboratory Testing Devices
        • Point-of-care Testing Devices
      • By Technology
        • Ion-Exchange HPLC
        • Immunoassay
        • Boronate Affinity Chromatography
        • Direct Enzymatic Assay
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Test Type:
        • Laboratory Testing Devices
        • Point-of-care Testing Devices
      • By Technology
        • Ion-Exchange HPLC
        • Immunoassay
        • Boronate Affinity Chromatography
        • Direct Enzymatic Assay
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Test Type:
        • Laboratory Testing Devices
        • Point-of-care Testing Devices
      • By Technology
        • Ion-Exchange HPLC
        • Immunoassay
        • Boronate Affinity Chromatography
        • Direct Enzymatic Assay
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Test Type:
        • Laboratory Testing Devices
        • Point-of-care Testing Devices
      • By Technology
        • Ion-Exchange HPLC
        • Immunoassay
        • Boronate Affinity Chromatography
        • Direct Enzymatic Assay
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Test Type:
        • Laboratory Testing Devices
        • Point-of-care Testing Devices
      • By Technology
        • Ion-Exchange HPLC
        • Immunoassay
        • Boronate Affinity Chromatography
        • Direct Enzymatic Assay
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Test Type:
        • Laboratory Testing Devices
        • Point-of-care Testing Devices
      • By Technology
        • Ion-Exchange HPLC
        • Immunoassay
        • Boronate Affinity Chromatography
        • Direct Enzymatic Assay
        • Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • ARKRAY, Inc.
    • Bio-Rad Laboratories, Inc.
    • Chek Diagnostics (Polymer Technology Systems, Inc.)
    • Danaher Corporation (Beckman Coulter)
    • F. Hoffmann-La Roche Ltd.
    • Menarini Group
    • Sebia
    • Siemens Healthcare
    • Tosoh Corporation
    • Trinity Biotech plc.
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Test Type
      • Market Snippet, By Technology
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Hemoglobin A1c Testing Devices Market, By Test Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Laboratory Testing Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Point-of-care Testing Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Hemoglobin A1c Testing Devices Market, By Technology, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Ion-Exchange HPLC
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Immunoassay
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Boronate Affinity Chromatography
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Direct Enzymatic Assay
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Hemoglobin A1c Testing Devices Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ARKRAY, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Chek Diagnostics (Polymer Technology Systems, Inc.)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Danaher Corporation (Beckman Coulter)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Menarini Group
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sebia
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Siemens Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Tosoh Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Trinity Biotech plc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 20 market data tables and 12 figures on “Hemoglobin A1c Testing Devices Market - Global forecast to 2027”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Data Triangulation Methodology | Coherent Market Insights

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Market Analysis | Coherent Market Insights

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.